Pancreatic Cancer Research

ResearcherFred and Pamela Buffett Cancer CenterActive in the last 2 years

Premila Devi Leiphrakpam

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2319-8844; OpenAlex author ID A5046816603. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes. Co-author DOI 10.1007/s12029-025-01183-2↗
  2. MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans. First author DOI 10.1016/j.canlet.2021.01.015↗
  3. Role of keratan sulfate expression in human pancreatic cancer malignancy. Co-author DOI 10.1038/s41598-019-46046-6↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chandrakanth Are · 1 shared paper, 2025 · strength 0.30
  2. Mashaal Dhir · 1 shared paper, 2025 · strength 0.30
  3. Prakash Radhakrishnan · 2 shared papers, 2019–2021 · strength 0.23
  4. Kyle L. McAndrews · 1 shared paper, 2021 · strength 0.13
  5. Divya Thomas · 1 shared paper, 2021 · strength 0.13
  6. Thomas C. Caffrey · 1 shared paper, 2021 · strength 0.13
  7. Satish Sagar · 1 shared paper, 2021 · strength 0.13
  8. Michael Anthony Hollingsworth · 1 shared paper, 2021 · strength 0.13
  9. Neeley A. Remmers · 1 shared paper, 2019 · strength 0.10
  10. Paul M. Grandgenett · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.